Axsome Therapeutics
AXSM
AXSM
173 hedge funds and large institutions have $827M invested in Axsome Therapeutics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 66 increasing their positions, 46 reducing their positions, and 25 closing their positions.
Holders
173
Holders Change
–
Holders Change %
0%
% of All Funds
2.93%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
27
Increased
66
Reduced
46
Closed
25
Calls
$106M
Puts
$110M
Net Calls
-$4.26M
Net Calls Change
-$34.4M
Top Buyers
1 |
PHS
1
PFM Health Sciences
San Francisco,
California
|
$52.1M |
2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$29.5M |
3 |
3
Millennium Management
New York
|
$13.3M |
4 |
4
Goldman Sachs
New York
|
$14.5M |
5 |
5
US Bancorp
Minneapolis,
Minnesota
|
$10.1M |